S

SwanBio Therapeutics

45 employees

SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neurology and Gene Therapy

Date founded

2018

Funding rounds raised

Total raised

$56M

from 4 investors over 4 rounds

S

SwanBio Therapeutics raised $56M on May 18, 2022

Investors: Syncona Limited

S

SwanBio Therapeutics raised $52M on April 23, 2020

Investors: Partners HealthCare and Syncona Limited

S

SwanBio Therapeutics raised undisclosed on January 1, 2018

Investors: Syncona Limited

FAQ